How to Buy Standard Biotools Stock
Standard Biotools Inc
Standard BioTools Inc. , together with its subsidiaries, develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop therapeutics in the Americas, Europe, the Middle East, Africa, and the Asia pacific.
Standard Biotools stock last closed at $1.45, down 2.03% from the previous day, and has decreased 24.48% in one year. It has underperformed other stocks in the Diagnostics & Research industry by 0.37 percentage points. Standard Biotools stock is currently +57.61% from its 52-week low of $0.92, and -35.56% from its 52-week high of $2.25.
At the moment, there are 384.57M LAB shares outstanding. The market cap of LAB is $557.62M. In the past 24 hours, 958,000 LAB shares were traded.
How to Buy Standard Biotools Stock
Not sure how to invest in Standard Biotools stock? Here's how.
- Figure out where to buy Standard Biotools stock: You need to pick a stock brokerage, but don't worry - we've tried dozens of stock brokerages and apps to help you decide where to buy Standard Biotools stock.
- Sign up for a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
- Deposit funds into your investment account: Pick your method of payment and add your details.
- Analyze Standard Biotools stock: The Standard Biotools ticker symbol is LAB. Is Standard Biotools stock a good investment? Should you buy shares of LAB? How do LAB's underlying business fundamentals look? Do top analysts think Standard Biotools is a good buy? Why has LAB's stock price moved recently? (Hint: Our stock market research website can help you evaluate if LAB is a good stock to buy).
- Execute your LAB buy order: Decide if you will purchase LAB shares at the current market price or use a limit order to purchase LAB shares at a given price.
- Get the latest news on your investment in LAB: Create a watchlist to get the latest news on your position in Standard Biotools shares.
Step 1: Figure out where to buy Standard Biotools stock
You will need a brokerage account in order to access the NASDAQ market and buy LAB shares.
Our recommended brokerage: eToro
Based on our experience, eToro is the best place to buy stocks. Here's why:
- You can invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
- Access to global markets: From Technology to Energy, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top stock exchanges.
- Social investing: eToro offers a community of more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your stock purchase by opening an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Sign up for a brokerage account
Now that you've chosen the right brokerage, you need to fill out some personal information so you are able to buy LAB today.
How to Set Up a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal data to create a new trading account.
- Send your information by clicking the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your investment account
Now that you have opened your account on the best stock trading app, your next step is to transfer the money for your investment:
Watch the video below for more details depositing funds into your new brokerage account.
Step 4: Analyze Standard Biotools stock
Once you have figured out the best place to buy Standard Biotools stock, it's crucial to evaluate their stock before you invest, so you actually comprehend the risk and upside.
Standard Biotools stock quick numbers
Standard Biotools Due Diligence Score
WallStreetZen was built to help average investors do more in-depth fundamental analysis.
You can view all of the due diligence checks on LAB's stock page.
What is the fair value of LAB stock?
Investors use many financial metrics, analyses, models, and charts to gauge LAB's fair value.
Using relative valuations measures:
- LAB may be undervalued based on its P/B ratio of 1.4x, relative to Diagnostics & Research industry P/B ratio of 4.45x
You can access more valuation analysis on LAB's stock here.
LAB Financials at a glance
Signs that LAB is financially healthy:
- There are more short-term assets than short-term liabilities on the LAB balance sheet.
- There are more short-term assets than long-term liabilities on the LAB balance sheet.
- LAB has a low debt to equity ratio of 0.35.
- LAB has cash burn of 98421000. It has enough cash and short-term investments to cover this for at least one year.
- Total LAB debt is lower than 5 years ago, relative to shareholder equity.
- LAB has $194.90M in cash and short term investments. This is sufficient to cover its annual cash burn of $98.42M.
Signs that LAB is not financially healthy:
- LAB profit margin has gone up by 0.45 percentage points in the past year, but the company is still unprofitable.
Is it a good time to buy LAB stock, according to Wall Street analysts?
Out of 1 sell side analysts who track LAB, the consensus analyst rating on LAB is a Hold
It's important to note that analyst forecasts are not stock recommendations, nor are they financial advice.
You can dig deeper into what analysts are projecting on the Standard Biotools stock forecast page.
LAB Momentum
Is LAB Making Money?
Last year, LAB revenue was $128.83M. In the past five year, LAB's revenue has grown by 0.45% per year. This was slower than the Diagnostics & Research industry average of 9.37%.
Dive into LAB's earnings and revenue performance here.
What are LAB insiders up to?
In the past year, insiders at LAB have bought more shares than they have sold.
Casdin Partners Master Fund LP, Director of LAB, was the latest LAB insider to buy. They bought $217,050.00 worth of LAB stock on Dec 4, 2025.
Research more about who owns LAB stock here.
Does LAB stock generate passive income?
No, Standard Biotools doesn't provide an income stream by paying out dividends.
LAB Social Trading Data
One of the primary reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other investors have to say.
Step 5: Execute your LAB buy order
You have two main order types:
- Market order: A market order is an order to buy or sell a stock at the best price on the market.
Market orders are mostly the best for newer investors. - Limit order: A limit order allows you to buy or sell a stock at a specific price (or better).
If you want to be certain you're buying or selling at a specific dollar amount limit, use a limit order.
Click the Open Trade button and eToro will place your order.
If you want additional help buying stocks on eToro, watch the how to video below:
Step 6: Get the latest news on your investment in LAB
Now that you own some shares in LAB, you'll want to stay up-to-date on your company.
Put LAB on a watchlist to keep tabs on your LAB stock.
LAB Feed
How to Buy Stock in Standard Biotools
To summarize, here are the 6 steps to buy stock in Standard Biotools:
- Figure out where to buy Standard Biotools stock
- Sign up for a brokerage account
- Deposit funds into your investment account
- Analyze Standard Biotools stock
- Execute your LAB buy order
- Get the latest news on your investment in LAB
If you need a brokerage, eToro is our recommended option.
Get Started with eToro TodayIf you want to get the latest news on your investment in Standard Biotools, create a watchlist on WallStreetZen today.
Other Stock Buying Guides You May Enjoy
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.